RE: Brilliant RNS14 Oct 2020 19:39
Apologies if already posted...
'Following a positive pre-Investigational New Drug (IND) Application meeting with the U.S. Food and Drug Administration (FDA) regarding the design of a Phase III randomised placebo-controlled trial of SNG001 in hospitalised COVID-19 patients, and with manufacturing scale-up activity underway, the Company is pleased to announce the proposed Fundraising of up to £87.0 million to support the Phase III clinical development and supply chain scale-up of SNG001 for COVID-19 patients.'